|Name of company||Lily MedTech Inc.|
|Established||May 9, 2016|
|Capital||JPY 732.01 million (Including capital reserves) (as of Date April 2019)|
|Description of business||Development of medical devices|
|Location||Entrepreneur Plaza 701 at the University of Tokyo|
7-3-1 Hongo Bunkyo-ku, Tokyo 113-0033
I was motivated to start this company when, as a high school student, I lost my mother to cancer.
Thank you for visiting Lily MedTech, Inc.’s website.
Our company is a venture startup from the University of Tokyo with a mission to save women from breast cancer.
|March 2015||Received the Award of Excellence at the NCC Venture Grand Prix 2015 hosted by Nissei Capital Co., Ltd.|
|November 2015||Completion of the first prototype unit at Azuma Laboratory, the University of Tokyo.|
|March 2016||Adopted as NEDO STS-subsidized project.|
|May 2016||Founding and Establishment of company. Joint research agreement was concluded with the University of Tokyo.|
|October 2016||Completion of the second prototype unit.|
|November 2016||Started clinical trials at the Tsukuba International Breast Clinic.|
|December 2016||Started clinical trials at the University of Tokyo Hospital.|
|August 2017||Selected for 99th New Technology Development subsidy by The New Technology Development Foundation.|
|August 2017||Received University Venture Recognition 2017 Early Edge Prize at Innovation Japan 2017|
|October 2017||Selected to be AMED-subsidized Medical device development promotion research project.|
|February 2018||Selected as Next generation innovative creation project 2020 subsidized project by the Tokyo Metropolitan Small and Medium Enterprise Support Center|
|March 2018||Raised 350 million JPY in funding via From Beyond Next Ventures Co., Ltd., JST, and others.|
|December 2018||Selected for University-led venture support business by Bunkyo-City.|
I was motivated to start this company when, as a high school student, I lost my mother to cancer. My mother unexpectedly suffered from a highly malignant brain tumor which affects only 1 out of 100,000 people. The extremely low 5 year survival rate of this type of cancer saw her pass away at the age of 46 after battling the disease for a year and a half.
Even back then, I knew that the survival rate of the disease was low, but we still tried various treatments. As my mother’s treatment progressed, she lost weight, lost her hair, and did not want to go out anymore. This fact that we lost her as a family member deeply changed my family. Because of this experience, I wanted to spare others from having to go through the same kind of experiences as I did. This spirit is what led to me start my own business. However, watching my mother live almost exactly the length of time the doctor initially stated led to me realize the limitations of current medical treatment. As a result, I decided on a field other than medicine after graduating from high school.
Not that long ago I heard about ultrasonic CT techniques from my husband, who is studying medical ultrasound at the University of Tokyo. While talking about the concept of breast cancer examination and diagnostic devices, we realized that, unlike many other cancers, breast cancer affects a larger percentage of younger adults. If the cancer is found at an early stage, the survival rate is actually quite high, and I realized that the earlier we could detect breast cancer, the further we could reduce the mortality rate and shorten the treatment period, unlike the disease which affected my mother.
Breast cancer is a curable disease now. Their 30s, 40s, and 50s are times in women’s lives when they have many choices and opportunities, such as a career, romance, marriage, childbirth, and child rearing. With our device, I hope to give affected women a chance to live as well as they did before being affected by cancer, because no woman should have to miss out on the great opportunities of life.
I have been engaged in research and development of medical diagnostic devices for many years. Last year, I became aware of the ultrasonic breast cancer examining technology project which was to become our company’s technical base, and decided to participate, which I continue to do to this day.
Every member of our company is united by the same unbreakable spirit: if we can reduce by even one person the number of women suffering from cancer and keep the smiles on their families’ faces, our research and development has served its purpose. With the leadership of a CEO with clear passion and a strong sense of mission, we are working day by day toward obtaining reliable results through better technology.
When developing new technologies from the perspective of that technology alone, there is a risk that the end result may not actually match the real-world needs of the medical field. At our company, through our focus on the collaboration of both medicine and engineering, and with the support of the University of Tokyo Hospital, we are confident that our device has been developed with the needs of the medical community, as well as the patients, fully in mind.
If you are interested in joining us, by all means contact us from the "Careers" page.